ReviewAntioxidants (Basel, Switzerland)2026
Advances in Synthetic Strategies for Microalgal Carotenoid Enhancement and Emerging Applications.
Review in Antioxidants (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Carotenoids are increasingly studied for their robust antioxidant capacity, anti-inflammatory potential, protective vision and validated contribution to human health. Carotenoids are mainly obtained through chemical synthesis and plant extraction, which results in relatively high costs for producing carotenoids. However, microalgae represent a sustainable and high-yield platform for natural carotenoid production, with advantages including rapid growth, high pigment accumulation, and broad environmental adaptability. This review summarizes recent biotechnological advances in enhancing carotenoid production, with a focus on metabolic engineering, environmental regulation, and cultivation strategies. CRISPR/Cas9 enables precision metabolic pathway engineering, while environmental factors like light, nutrients, and stress significantly influence yield. Different cultivation strategies allow carotenoids to fulfill commercial or research needs. The two-stage strategy achieves rapid biomass increase during the growth stage, then shifts to accumulate carotenoids. This regulatory mode significantly reduces cell death by continuous stress, providing high productivity and stability in large-scale production. Carotenoids participate in many innovative applications across various fields, including treatments in medicine, skin protection in cosmetics, protein stabilization in foods, enhancing animals' survival and so on. Future research will integrate bioprocess optimization, precision strain engineering, and adaptive environmental strategies to scale high-value microalgal carotenoid production as a commercially and environmentally viable solution.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.